COMPARATIVE STUDY
JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
Add like
Add dislike
Add to saved papers

Pathology of Chronic Total Occlusion in Bare-Metal Versus Drug-Eluting Stents: Implications for Revascularization.

OBJECTIVES: The aim of this study was to explore the pathology of in-stent chronic total occlusion (IS-CTO) in bare-metal (BMS) versus drug-eluting stents (DES).

BACKGROUND: Despite a relatively high prevalence of IS-CTO, little is known about the underlying etiology and histopathologic characteristics of the occlusion.

METHODS: From CVPath Institute's stent registry of human native coronary arteries, the authors identified 56 lesions (32 BMS and 24 DES) from 54 patients with IS-CTO. Sections of stented coronary arteries were examined for histological features of IS-CTO. The underlying mechanisms of IS-CTO were determined along with the histopathological characteristics.

RESULTS: The pathological prevalence of IS-CTO was significantly higher in BMS versus DES cases at autopsy (11.7% vs. 5.9%; p = 0.01). The most frequent etiology of IS-CTO was acute thrombotic occlusion (51% in BMS vs. 67% in DES), followed by restenosis (31% vs. 8%) and neoatherosclerotic rupture (9% vs. 4%). The proximal lumen pattern was abrupt in 67% of BMS and in 57% of DES, whereas the distal lumen was tapered in 68% of BMS and in 74% of DES. BMS showed longer fibrous cap of IS-CTO than DES in both proximal (4.6 mm vs. 1.6 mm; p = 0.06) and distal (5.3 mm vs. 2.0 mm; p = 0.06).

CONCLUSIONS: At autopsy, IS-CTO was observed more frequently in BMS versus DES, with acute thrombotic occlusion being the most frequent cause, followed by restenosis (especially in BMS) and neoatherosclerotic rupture. Our findings shed new light upon the frequency, mechanisms, and pathology of IS-CTO.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app